Competing interests
Johnson & Johnson, and Asahi Surgical Robotics
SK reports honoraria from Ono, Johnson & Johnson, and Asahi Surgical Robotics.HB reports research funding from Takeda, Daiichi Sankyo, and Sysmex, and honoraria from Takeda, Chugai, Taiho, and Eli Lilly.ES reports honoraria from Takeda, Merck, Eli Lily, and Chugai.MS reports honoraria from Eli Lilly, Takeda, Taiho, Ono, Yakult, and Merck.HH reports honoraria from Bayer, Bristol-Myers Squibb, Chugai, Daiichi Sankyo, Kyowa Hakko Kirin, Eli Lilly, Merck, MSD, Ono, Taiho, Takeda, and Yakult, having consulting or advisory roles in Bristol-Myers Squibb, Boehringer Ingelheim, Daiichi Sankyo, Dainippon Sumitomo, MSD, and Ono, and receiving research grants from ALX oncology, Amgen, Astellas, AstraZeneca, Bayer, BeiGene, Boehringer Ingelheim, Bristol-Myers Squibb, Chugai, Daiichi Sankyo, Eisai, Janssen, Merck, MSD, Ono, and Taiho.KY reports honoraria from Chugai, Daiichi Sankyo, Yakult, Takeda, Bayer, Merck, Taiho, Eli Lilly, Sanofi, Ono, MSD, and Bristol-Myers Squibb.NM reports honoraria from Merk and research funding from Ono.YK reports honoraria from Chugai, Eli Lilly, Takeda, Bayer Yakuhin, Taiho, MSD, Ono, Yakult, Merck, and Sanofi.EO reports research funding from Guardant Health and honoraria from Ono, Takeda, Bayer, Chugai, Taiho, Eli Lilly, and Bristol-Myers Squibb.ST reports honoraria from Taiho and VIATRIS.AT, TT, KK, MY, TK, and MW have no conflicts to declare.TY reports research funding from Novartis Pharma, MSD, Sumitomo Dainippon, Chugai, Sanofi, Daiichi Sankyo, Parexel, and Ono.